APA

Wang H., Yu N., Chen D., Lee K. C. L., Lye P. L., Chang J. W. W., Deng W., Ng M. C. Y., Lu T., Khoo M. L., Poulsen A., Sangthongpitag K., Wu X., Hu C., Goh K. C., Wang X., Fang L., Goh K. L., Khng H. H., Goh S. K., Yeo P., Liu X., Bonday Z., Wood J. M., Dymock B. W., Kantharaj E. & Sun E. T. (20110923). Discovery of (2E)-3-{2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide (SB939), an orally active histone deacetylase inhibitor with a superior preclinical profile. : Journal of medicinal chemistry.

Chicago

Wang Haishan, Yu Niefang, Chen Dizhong, Lee Ken Chi Lik, Lye Pek Ling, Chang Joyce Wei Wei, Deng Weiping, Ng Melvin Chi Yeh, Lu Ting, Khoo Mui Ling, Poulsen Anders, Sangthongpitag Kanda, Wu Xiaofeng, Hu Changyong, Goh Kee Chuan, Wang Xukun, Fang Lijuan, Goh Kay Lin, Khng Hwee Hoon, Goh Siok Kun, Yeo Pauline, Liu Xin, Bonday Zahid, Wood Jeanette M, Dymock Brian W, Kantharaj Ethirajulu and Sun Eric T. 20110923. Discovery of (2E)-3-{2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide (SB939), an orally active histone deacetylase inhibitor with a superior preclinical profile. : Journal of medicinal chemistry.

Harvard

Wang H., Yu N., Chen D., Lee K. C. L., Lye P. L., Chang J. W. W., Deng W., Ng M. C. Y., Lu T., Khoo M. L., Poulsen A., Sangthongpitag K., Wu X., Hu C., Goh K. C., Wang X., Fang L., Goh K. L., Khng H. H., Goh S. K., Yeo P., Liu X., Bonday Z., Wood J. M., Dymock B. W., Kantharaj E. and Sun E. T. (20110923). Discovery of (2E)-3-{2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide (SB939), an orally active histone deacetylase inhibitor with a superior preclinical profile. : Journal of medicinal chemistry.

MLA

Wang Haishan, Yu Niefang, Chen Dizhong, Lee Ken Chi Lik, Lye Pek Ling, Chang Joyce Wei Wei, Deng Weiping, Ng Melvin Chi Yeh, Lu Ting, Khoo Mui Ling, Poulsen Anders, Sangthongpitag Kanda, Wu Xiaofeng, Hu Changyong, Goh Kee Chuan, Wang Xukun, Fang Lijuan, Goh Kay Lin, Khng Hwee Hoon, Goh Siok Kun, Yeo Pauline, Liu Xin, Bonday Zahid, Wood Jeanette M, Dymock Brian W, Kantharaj Ethirajulu and Sun Eric T. Discovery of (2E)-3-{2-butyl-1-[2-(diethylamino)ethyl]-1H-benzimidazol-5-yl}-N-hydroxyacrylamide (SB939), an orally active histone deacetylase inhibitor with a superior preclinical profile. : Journal of medicinal chemistry. 20110923.